Unannounced · 612 daysFiled 13 January 2025
Cambrian BioPharma Inc has sold $23M so far
Cambrian BioPharma Inc, a pharmaceuticals company based in New York, NY, has sold $23M so far in its SAFE round, according to a filing dated 13 January 2025.
No public announcement found as of 16 September 2026, 612 days after the filing.
- Filed
- 13 January 2025
- First filed
- 22 December 2023
- Round
- Safe round (amended filing)
- Amount sold
- $23M
- Offering size
- $37.6M
- Investors so far
- 30
- Based in
- New York, NY
- Website
- cambrianbio.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 76% of the 1,404 tracked raises with an amount filed in 2025.
Cambrian BioPharma Inc in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 15 Jul 2026 | New filing | $124M | Not tracked |
| 13 Jan 2025 | Amended filing | $23M | This raise |
| 22 Dec 2023 | New filing | $7.69M | This raise |
| 2 Dec 2021 | New filing | $92.2M | Another raise |
| 6 May 2021 | New filing | $28.4M | Another raise |
More with Future Ventures on the board
- Gameto, Inc.$44M
- Realta Fusion Inc.$35.5M
- Earthshot Labs PBC$1.7M
- Ockam Inc.$12.5M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.